why choose us

First received: November 19, 2025

Clinical Trial: ENX-205 SAD/PET Study in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Volunteer

Study Type: INTERVENTIONAL


Official Title: A Two-Part, Single Ascending Dose and Positron Emission Tomography Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Receptor Occupancy After Single Oral Dose Administration of ENX-205

Brief Summary: This is a two-part study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and receptor occupancy (RO) of ENX-205 in healthy adult participants in a double-blind placebo-controlled, single ascending dose (SAD) study (Part 1) and an open-label, single-dose, positron emission tomography (PET) study (Part 2).

Read more